Kolexia
Gruel Yves
Anesthesie-réanimation
CHU Tours
Tours, France
132 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Thrombopénie Thrombose Hémorragie COVID-19 Thromboembolie Hémophilie A Thromboembolisme veineux Prédisposition génétique à une maladie Urgences

Industries

VIATRIS SANTE
2 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?
Blood advances   31 juillet 2023
Laboratory and demographic predictors of functional assay positive status in suspected heparin-induced thrombocytopenia: A multicenter retrospective cohort study.
Thrombosis research   20 juillet 2023
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.
European journal of haematology   13 juillet 2023
TRANSHEMO: Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia - TRANSHEMO
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   13 février 2023
Vascular endothelial growth factor, tissue factor, coagulation and fibrinolysis markers in slow-flow vascular malformations: a prospective study of treatment with sirolimus.
The British journal of dermatology   25 janvier 2023
Modulation of ultralarge immune complexes in heparin-induced thrombocytopenia.
Journal of thrombosis and haemostasis : JTH   22 décembre 2022
VEGF, facteur tissulaire, marqueurs de la coagulation et de la fibrinolyse dans les malformations vasculaires à flux lent : étude prospective et impact du sirolimus
Journées dermatologiques de Paris, 29 novembre - 3 décembre 2022   01 novembre 2022
Breast cancer cell-based ELISA: a potential material for better detection of heparin-induced thrombocytopenia antibodies.
Journal of materials chemistry. B   05 octobre 2022
The deglycosylated form of 1E12 inhibits platelet activation and prothrombotic effects induced by VITT antibodies.
Haematologica   01 octobre 2022
Variable serotonin release assay pattern and specificity of PF4-specific antibodies in HIT, and clinical relevance.
Journal of thrombosis and haemostasis : JTH   02 septembre 2022